Eliem Therapeutics, Inc. Contracts & Agreements
23 Contracts & Agreements
- Business Finance (5 contracts)
- Business Operations (1)
- Human Resources (14)
- Mergers & Acquisitions (1)
- Uncategorized (2)
- Separation and Consulting Agreement, dated February 13, 2023, by and between Eliem Therapeutics, Inc. and James B. Bucher (Filed With SEC on March 28, 2024)
- Executive Employment Agreement by and between the Eliem Therapeutics, Inc. and James B. Bucher, effective October 1, 2020 (Filed With SEC on March 28, 2024)
- Separation and Consulting Agreement, dated February 13, 2023, by and between Eliem Therapeutics, Inc. and Erin Lavelle (Filed With SEC on February 14, 2023)
- Separation and Consulting Agreement, dated February 13, 2023, by and between Eliem Therapeutics, Inc. and Robert Azelby (Filed With SEC on February 14, 2023)
- Description of Securities (Filed With SEC on March 7, 2022)
- 2021 Equity Incentive Plan (Filed With SEC on August 2, 2021)
- Executive Employment Agreement by and between the Registrant and Erin M. Lavelle, effective October 1, 2021, as amended (Filed With SEC on August 2, 2021)
- Executive Employment Agreement by and between the Registrant and Bob Azelby, effective October 1, 2021, as amended (Filed With SEC on August 2, 2021)
- Form of Indemnification Agreement, by and between the Registrant and each of its directors and executive officers (Filed With SEC on August 2, 2021)
- 2021 Employee Stock Purchase Plan (Filed With SEC on August 2, 2021)
- Forms of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the 2021 Equity Incentive Plan (Filed With SEC on August 2, 2021)
- Forms of Option Agreement, Stock Option Grant Notice and Notice of Exercise under the 2021 Equity Incentive Plan (Filed With SEC on August 2, 2021)
- Forms of Option Agreement and Notice of Exercise under the 2019 Equity Incentive Plan (Filed With SEC on August 2, 2021)
- Form of common stock certificate of the Registrant (Filed With SEC on August 2, 2021)
- Form of Underwriting Agreement (Filed With SEC on August 2, 2021)
- Unit Transfer Agreement, dated February 4, 2019, by and between the Registrant and the Members of NeoKera, LLC (Filed With SEC on July 16, 2021)
- Executive Employment Agreement by and between Eliem Therapeutics (UK) Ltd. and Valerie Morisset, Ph.D., effective January 1, 2021 (Filed With SEC on July 16, 2021)
- Executive Employment Agreement by and between the Registrant and Erin M. Lavelle, effective October 1, 2021 (Filed With SEC on July 16, 2021)
- Executive Employment Agreement by and between the Registrant and Bob Azelby, effective October 1, 2021 (Filed With SEC on July 16, 2021)
- 2019 Equity Incentive Plan, as amended (Filed With SEC on July 16, 2021)
- Amended and Restated Investor Rights Agreement, dated May 21, 2021, by and among the Registrant and the investors listed on Schedule A thereto (Filed With SEC on July 16, 2021)
- Agreement and Plan of Merger and Reorganization, dated October 15, 2020, by and among the Registrant, Athena Merger Sub Inc., Athenen Therapeutics, Inc., AI ETI LLC, as Eliem... (Filed With SEC on July 16, 2021)
- Asset Contribution Agreement, dated February 4, 2019, by and between the Registrant and Carnot, LLC (Filed With SEC on July 16, 2021)